Please assess the completion status of the following clinical trial:

Trial Title: Hepatic Effects of Gastric Bypass Surgery

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. BMI \> 40.~2. Documented failed non-surgical treatment for morbid obesity.~3. Ability to undergo long-term follow-up after LGBS.~Exclusion Criteria:~1. BMI \< 40.~2. Subject age \< 18 years.~3. Inability to undergo long-term follow-up after LGBS (living distance \> 300 miles).~4. Patients with known ESLD.~5. Patients found to have evidence of ESLD during preoperative evaluation for LGBS including portal hypertension, ascites, and coagulopathy.~6. Patients with known iodine sensitivity or allergy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- liver function (Type: OTHER): Subjects undergoing laparoscopic gastric surgery will be evaluated for liver function by comparing liver tissue biopsied during surgery with tissue biopsied after 60% weight loss

Based on this trial design, predict the completion outcome and termination type (if applicable).